Literature DB >> 10913613

The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells.

K Smalley1, T Eisen.   

Abstract

Activation of p38 or p44/42 mitogen-activated protein (MAP) kinases has been shown to trigger differentiation in a number of cell types. The present study has investigated the roles of these kinases in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and proliferative responses in B16 melanoma cells. Treatment of cells with alpha-MSH led to the time-dependent phosphorylation of both p38 and p44/42 MAP kinases. However, only inhibition of p38 MAP kinase activity with SB 203580 blocked both the alpha-MSH-induced melanogenic and anti-proliferative effects. It therefore appears that activation of the p38 pathway can promote melanogenesis and inhibit growth of B16 melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913613     DOI: 10.1016/s0014-5793(00)01726-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

1.  Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.

Authors:  P A van der Velden; L A Sandkuijl; W Bergman; S Pavel; L van Mourik; R R Frants; N A Gruis
Journal:  Am J Hum Genet       Date:  2001-08-07       Impact factor: 11.025

2.  The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression.

Authors:  M D Galibert; S Carreira; C R Goding
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

3.  Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.

Authors:  Yuan Lu; Mikki Boswell; William Boswell; Susanne Kneitz; Michael Hausmann; Barbara Klotz; Janine Regneri; Markita Savage; Angel Amores; John Postlethwait; Wesley Warren; Manfred Schartl; Ronald Walter
Journal:  Pigment Cell Melanoma Res       Date:  2018-01-29       Impact factor: 4.693

4.  Docosahexaenoic acid inhibits melanin synthesis in murine melanoma cells in vitro through increasing tyrosinase degradation.

Authors:  Marie Carmel Balcos; Su Yeon Kim; Hyo-soon Jeong; Hye-young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Kyoung-chan Park; Dong-seok Kim
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

5.  Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation.

Authors:  Orly Ordan; Ronit Rotem; Ilona Jaspers; Eliezer Flescher
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.

Authors:  Carsten Denkert; Antje Siegert; Anja Leclere; Andreas Turzynski; Steffen Hauptmann
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 7.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

8.  p38 regulates pigmentation via proteasomal degradation of tyrosinase.

Authors:  Barbara Bellei; Vittoria Maresca; Enrica Flori; Angela Pitisci; Lionel Larue; Mauro Picardo
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

9.  Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.

Authors:  Tokimasa Hida; Kazumasa Wakamatsu; Elena V Sviderskaya; Andrew J Donkin; Lluis Montoliu; M Lynn Lamoreux; Bin Yu; Glenn L Millhauser; Shosuke Ito; Gregory S Barsh; Kowichi Jimbow; Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-26       Impact factor: 4.693

10.  The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

Authors:  Kristian Otkjaer; Helmut Holtmann; Tue Wenzel Kragstrup; Søren Riis Paludan; Claus Johansen; Matthias Gaestel; Knud Kragballe; Lars Iversen
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.